Adial Pharmaceuticals Inc (ADIL) Analysis & Forecast for 2025

Adial Pharmaceuticals Inc (NASDAQ: ADIL) is -79.15% lower on its value in year-to-date trading and has touched a low of $0.22 and a high of $3.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ADIL stock was last observed hovering at around $0.26 in the last trading session, with the day’s gains setting it 0.88%.

Currently trading at $1.14M, the stock is -53.85% and -62.40% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 57.65 million and changing 57652492% at the moment leaves the stock -73.20% off its SMA200. ADIL registered -77.30% loss for a year compared to 6-month loss of -79.34%. The firm has a 50-day simple moving average (SMA 50) of $0.6102 and a 200-day simple moving average (SMA200) of $0.85565.

The stock witnessed a -68.11% gain in the last 1 month and extending the period to 3 months gives it a -67.70%, and is -29.47% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.90% over the week and 10.78% over the month.

Adial Pharmaceuticals Inc (ADIL) has around 7 employees, a market worth around $3.62M and $0.00M in sales. Distance from 52-week low is 4.23% and -92.36% from its 52-week high. The company has generated returns on investments over the last 12 months (-420.83%).

The EPS is expected to grow by 61.03% this year.

Adial Pharmaceuticals Inc (ADIL) Top Institutional Holders

15.0 institutions hold shares in Adial Pharmaceuticals Inc (ADIL), with institutional investors hold 3.66% of the company’s shares. The shares outstanding are 15.78M, and float is at 15.50M with Short Float at 0.87%. Institutions hold 3.64% of the Float.

The top institutional shareholder in the company is UBS GROUP AG with over 83605.0 shares valued at $96146.0. The investor’s holdings represent 1.9988% of the ADIL Shares outstanding. As of 2024-06-30, the second largest holder is MANCHESTER CAPITAL MANAGEMENT LLC with 48097.0 shares valued at $55312.0 to account for 1.1499 of the shares outstanding. The other top investors are RENAISSANCE TECHNOLOGIES LLC which holds 34346.0 shares representing 0.8211% and valued at over $39498.0, while HRT FINANCIAL LP holds 0.6988 of the shares totaling 29228.0 with a market value of $33000.0.

Adial Pharmaceuticals Inc (ADIL) Insider Activity

Related Posts

News RTS
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.